1. Home
  2. SEPN vs TUYA Comparison

SEPN vs TUYA Comparison

Compare SEPN & TUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • TUYA
  • Stock Information
  • Founded
  • SEPN 2022
  • TUYA 2014
  • Country
  • SEPN United States
  • TUYA China
  • Employees
  • SEPN N/A
  • TUYA N/A
  • Industry
  • SEPN
  • TUYA Computer Software: Prepackaged Software
  • Sector
  • SEPN
  • TUYA Technology
  • Exchange
  • SEPN NYSE
  • TUYA Nasdaq
  • Market Cap
  • SEPN 1.0B
  • TUYA 1.0B
  • IPO Year
  • SEPN 2024
  • TUYA 2021
  • Fundamental
  • Price
  • SEPN $23.30
  • TUYA $1.90
  • Analyst Decision
  • SEPN Strong Buy
  • TUYA
  • Analyst Count
  • SEPN 4
  • TUYA 0
  • Target Price
  • SEPN $43.67
  • TUYA N/A
  • AVG Volume (30 Days)
  • SEPN 226.8K
  • TUYA 942.2K
  • Earning Date
  • SEPN 11-20-2024
  • TUYA 11-18-2024
  • Dividend Yield
  • SEPN N/A
  • TUYA N/A
  • EPS Growth
  • SEPN N/A
  • TUYA N/A
  • EPS
  • SEPN N/A
  • TUYA N/A
  • Revenue
  • SEPN $981,000.00
  • TUYA $280,969,000.00
  • Revenue This Year
  • SEPN N/A
  • TUYA $27.60
  • Revenue Next Year
  • SEPN N/A
  • TUYA $16.91
  • P/E Ratio
  • SEPN N/A
  • TUYA N/A
  • Revenue Growth
  • SEPN N/A
  • TUYA 33.25
  • 52 Week Low
  • SEPN $18.62
  • TUYA $1.28
  • 52 Week High
  • SEPN $27.47
  • TUYA $2.32
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • TUYA 64.47
  • Support Level
  • SEPN N/A
  • TUYA $1.76
  • Resistance Level
  • SEPN N/A
  • TUYA $1.84
  • Average True Range (ATR)
  • SEPN 0.00
  • TUYA 0.07
  • MACD
  • SEPN 0.00
  • TUYA 0.00
  • Stochastic Oscillator
  • SEPN 0.00
  • TUYA 74.04

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About TUYA Tuya Inc. each representing one

Tuya Inc is an IoT cloud development platform with a mission to build an IoT developer ecosystem and enable everything to be smart. The Company has pioneered a purpose-built IoT cloud development platform that delivers a full suite of offerings, including platform-as-a-service (PaaS) and Software-as-a-service (SaaS), to businesses and developers. Through its IoT cloud development platform, It has enabled developers to activate a vibrant IoT ecosystem of brands, OEMs, partners, and end users to engage and communicate through a broad range of smart devices. The company's revenue is derived from the PRC.

Share on Social Networks: